iCAN aims for discoveries and improved treatments through research at the interface of precision cancer medicine and digital health. The…

The efficacy of immunotherapies in the most common lymphoid malignancy, diffuse large B-cell lymphoma, has been modest. New findings on…

What do we know about cancer, and what are some of the current cancer research trends? This article highlights key…

Researchers at the University of Helsinki discovered how ovarian cancer hides from the body’s immune system. The findings will help…

What are the latest advances in cancer research and treatment? Listen to our new podcast miniseries to find out! The…

iCAN has received a grant of 14 million euros from the Academy of Finland for its second term. Coordinated by…

The new research findings help to understand mechanisms that lead to different types of intestinal tumors. They show that the…

A functional precision medicine study conducted in Finland demonstrates that treatment selection based on results from drug sensitivity testing of…

iCAN is part of the Academy of Finland’s Flagship Programme. The ten Flagships create high-quality research, sustainable solutions, and societal…

The newly discovered biomarker may help to distinguish which patients are more likely to benefit from treatment that helps the…